Abstract

Central venous oxygen saturation (ScVO2) is commonly used in clinical practice as a surrogate for cardiac output and delivery of oxygen to tissues. However, ScVO2 is invasive, as it requires central vein cannulation. A non-invasive alternative, such as End-Tidal Oxygen (ETO2), would be beneficial to patients, as it is painless, and without the risks of central vein cannulation. If a strong level of agreement exits and a correlation is present, ETO2 could be used as a non-invasive measure to determine the heart’s ability to circulate blood and oxygen to tissues.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.